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Objectives: To study the relation between rates of vascular interventions, amputations and mortality in a defined 
population. 
Design: Retrospective comparison between two consecutive 4-year periods. 
Setting: Swedish district hospital covering apopulation of 125 000. 
Material: Three hundred and sixty-seven lower limb amputations and 1080 vascular procedures. 
Results: The number of legs treated for limb-threatening schaemia with either evascularisation or amputation i creased 
from 269 to 289. The rate of vascular interventions for limb-threatening schaemia ncreased from the first to the second 
period by 65%, while the rate of amputations decreased by 23%. Limb salvage rate at 30 months increased from 37% to 
53% (p<O.O000). The reduced amputation rate was entirely related to primary amputations. The adjusted risk of 
amputation for patients treated in the second period was half of that for patients treated in the first period (relative risk = 
0.49, p =0.0001), while mortality was similar in both periods. Among survivors, the proportion of patients with intact 
legs was higher in the second period than in the first, while no difference was found between the two periods among 
deceased patients. 
Conclusion: Increased vascular intervention leads to improved limb salvage rates and reduced amputation rates. It is 
important for both ethical and economical reasons to identify good responders torevascularisation, because the choice of 
initial treatment will only influence limb salvage but not survival. 
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Introduction 
Despite a marked increase of vascular procedures 
during the last decades, and despite the fact that a 
great proportion of vascular procedures are performed 
in order to avoid amputation, 1 6it has not been con- 
vincingly shown that vascular intervention for leg 
ischaemia prevents amputation. Several recent retro- 
spective studies claim an inverse relation between 
the number of vascular econstructions and amputa- 
tions, ~15 but a causal relationship is difficult to 
show.  16'17 Other studies show increasing rates of both 
vascular econstructions and amputationsY -2° 
The hospital of Varberg is an average district hospital 
situated on the west coast of Sweden, covering a well 
defined population of 125 000 inhabitants. Vascular 
surgery in this hospital was deliberately reinforced, 
starting at the end of 1988. The present retrospective 
study was undertaken to compare the relationship 
between rates of vascular procedures, rates of am- 
putation and mortality in this well defined population 
during two consecutive periods, distinctly separated 
* Address correspondence to: L. Karlstr6m. 
by different attitudes to, and thereby rates of, vascular 
reconstructions. Special attention was paid to account 
separately for primary and secondary amputations 
and the indications for the vascular procedures. 
Material and Methods 
Data acquisition 
All arterial interventions and all major amputations 
between 1 January 1985 and 31 December 1992 were 
retrieved using four different registers: The Swedish 
Vascular Registry, SWEDVASC, >3 the National Re- 
gistry of the Swedish National Board of Health and 
Welfare, a local register maintained by the Department 
of Anaesthesiology, and another local register main- 
tained by the secretaries ofthe Departments ofGeneral 
Surgery and Orthopaedic Surgery. The latter register 
was the most rewarding. Cross-checking of these four 
registers resulted in as close to 100% acquisition of 
cases as ever possible. Demographic data, including 
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Table 1. Variables included in the amputation register. 
Personal identification number (includes date of birth and sex) 
Date of amputation 
Type of intervention coded according tothe Swedish National Board of Health and Welfare 
Side of amputation 
Level of amputation 
Department (General Surgery or Orthopaedic Surgery) 
Date of admission 
Date of discharge 
Diagnosis coded according toICD-9 
Evaluation before amputation byvascular surgeon 
Angiography before amputation 
Vascular intervention before amputation 
Death 
Date of death 
Cause of death coded according toICD-9 
mortality, were obtained from the tax authorities. 
Deaths were recorded until 31 December 1993, the 
maximum follow-up time being 9 years. Survival ana- 
lyses were performed only for patients treated for 
limb-threatening ischaemia. A special amputation re- 
gister had been established in the west coast region 
of Sweden for research purposes, including all major 
amputations performed in this area during 1992 (Drott 
C, personal communication). Identification umbers 
of these patients were scrutinised to find patients 
belonging to the catchment area of Varberg who might 
have been amputated atother neighbouring hospitals. 
A few patients had been referred to the Sahlgrenska 
University Hospital of Gothenburg for vascular e- 
construction, but these were mostly for complicated 
aortic reconstructions and carotid surgery, and their 
number was insignificant (Jivegard L, personal com- 
munication). 
included, i.e. amputations performed at or above the 
ankle level. Only six Syme's amputations were found, 
and these were recorded as below-knee amputations 
because they were all converted to below-knee am- 
putations hortly after the first amputation. 
Acute ischaemia was defined according to the Swed- 
ish Vascular Registry. 1-3 Chronic severe ischaemia was 
defined as rest pain, ulceration or gangrene due to 
arterial disease, regardless of ankle pressure. Limb- 
threatening ischaemia included both acute and chronic 
severe ischaemia, regardless of whether the first treat- 
ment was attempted revascularisation r primary am- 
putation. Primary amputation was defined as 
amputation not preceded by attempted re- 
vascularisation. Failed revascularisation was defined 
as attempted revascularisation f llowed by secondary 
amputation. 
Data entry 
Data were entered from the medical records into a 
personal computer, using a Paradox 4.0 ® application 
that controlled ata entry, minimising errors. 
Variables and definitions 
Vascular interventions were registered according to 
the variables and definitions of the Swedish Vascular 
Registry, SWEDVASC, 1-3 including preoperative risk 
factors, peroperative details and postoperative follow- 
up after 1 month and 1 year. Amputations were re- 
corded using the variables hown in Table 1. 
Interventions and amputations performed for other 
reasons than arterial disease (e.g. trauma and malig- 
nancy) were excluded. Only major amputations were 
Data management 
Data were merged into an SPSS 6.0 ®21 data file. Each 
leg was recorded as one observation; thus bifurcated 
grafts were recorded as two observations, one for each 
leg. Data were grouped into two periods by the date 
of the first vascular intervention or, in the case of 
primary amputation, the date of the first amputation. 
Both periods were 4 years, the first from 1 January 
1985 to 31st December 1988, and the second from 1 
January 1989 to 31 December 1992. Grouping was 
made separately for extremities and for patients. Ex- 
cept for descriptive statistics including analyses of 
reoperations and redo procedures, only initial pro- 
cedures ("first vascular procedure for leg/patient" or 
"first amputation for leg/patient") were included in 
the analyses. 
To make comparisons possible between groups of 
patients with limb-threatening ischaemia, survival and 
limb salvage rate were calculated from the day of 
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Table 2. Mean age, sex distribution and proportion of diabetics among patients treated for peripheral arterial disease, by treatment 
and indication. Except for number of patients there were no statistically significant differences between the two periods in any of the 
subgroups. 
Period 
Vascular Revascularisation Revascularisation Revascularisation 
intervention for for chronic severe for acute ischaemia or amputation for 
any indication ischaemia limb-threatening 
ischaemia 
1 2 1 2 1 2 1 2 
Primary 
amputation for 
limb-threatening 
ischaemia 
1 2 
No of patients 228 410 68 104 69 80 232 257 95 73 
Mean age 74.4 72.4 75.6 76.5 79.2 80.2 79.4 78.8 81.9 80.3 
Males % 57.5 54.4 58.8 48.9 46.4 50.0 50.0 51.6 46.3 56.2 
Diabetics % 22.2 24.1 34.5 45.1 21.0 18.2 29.6 34.8 40.0 47.9 
amputation for those patients who underwent primary 
amputation and from the day of attempted re- 
vascularisation for the others. 
Statistics were performed using the SPSS 6.0 ® 
software. 2~ Proportions were compared using the Chi- 
squared test. Cumulative survival and cumulative limb 
salvage rate were calculated according to Kaplan- 
Meier, and the statistical significance of differences 
between the two periods was tested using the log rank 
test, adjusting for age, sex and diabetes using the Cox 
regression model. The relative risks between the two 
periods of death and amputation were calculated at 
different time intervals from the date of the first inter- 
vention using logistic regression, adjusting for age, 
sex and diabetes, as well as for choice of first treatment. 
Values of p less than 0.05 were considered statistically 
significant. 
Results 
Population 
During the first period the mean population of the 
catchment area of the hospital of Varberg amounted 
to 118 510 people, 18 295 of whom (15.4%) were aged 
65 or older. During the second period the mean popu- 
lation was 126 951, and 19 869 (15.6%) were aged 65 
or older. During the first period 323 patients were 
treated for peripheral arterial disease with either re- 
vascularisation or amputation; during the second 
period, 483. Mean age, sex distribution and proportion 
of diabetics are shown by treatment modality and 
indication in Table 2. 
Vascular procedures 
During the first period 408 vascular procedures were 
performed and during the second, 672. The annual 
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Fig. 1. Indications for vascular intervention, represented by numbers 
of legs treated within each period. "Other indications" include 
embolectomies of the upper extremity, vascular access and other 
miscellaneous procedures. ([B) First period; ( I )  Second period. 
rate of vascular procedures was constant within each 
period. The number of treated legs increased from 290 
to 505. The number of treated legs are shown by 
indication in Fig. 1. 
The number of reoperations within 30 days de- 
creased from 83 to 65 in spite of the increased number 
of vascular procedures (p<0.0000). The number of 
emergency procedures (reoperations within 30 clays 
excluded) increased from 150 to 203, but in relation 
to the increased number of vascular procedures the 
proportion of emergency procedures decreased from 
46.2% to 33.4% (p<0.0002). 
Limb threatening ischaemia 
The number of legs treated for limb threatening isch- 
aemia, i.e. chronic severe or acute ischaemia, with 
either primary amputation or attempted re- 
vascularisation, increased by 20, from 269 to 289, but 
the number of amputated legs in this group decreased 
by 30, from 165/269 (61%) to 135/289 (47%, p<0.0003). 
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Table 3. Legs treated for limb-threatening ischaemia during period 1 and 2, by procedure and result. The relative risk of amputation 
is the odds for legs treated in the second period divided by the odds for legs treated in the first period. Including reoperations and 
reamputations, 180 revascularisations and 200 amputations were performed during period 1, and 254 revascularisations and 156 
amputations during period 2. 
Number of legs % of legs 
Treatment Period 1 Period 2 Period 1 Period 2 
Crude relative risk Relative risk, adjusted 
of amputation for age, sex, diabetes 
RR P RR P 
Primary amp 114 79 42 27 *0.45 0.0000 *0.43 0.0000 
Secondary amp 51 56 19 20 ]-0.64 0.06 t0.63 0.05 
Successful revasc 104 154 39 53 
Total 269 289 100 100 $0.51 0.0001 ~:*0.49 0.0001 
* Primary amputation vs. successful revascularisation (n =451). 
t Secondary amputation vs. successful revascularisation (n = 365). 
J/Primary or secondary amputation vs. successful revascularisation (n = 558). 
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Fig. 2. Limb salvage rate for legs treated with either primary 
amputation rattempted revascularisation f r limb-threatening isch- 
aemia during the two periods. The initial straight vertical part of 
the curve reflects primary amputations, and the remaining curved 
line secondary amputations. 
Considering the increasing population, the expected 
number of amputated legs should have been at least 
180 during the second period. Thus, the expected 
amputation rate decreased by at least 45. The reduced 
amputation rate was entirely related to primary am- 
putations, secondary amputations being stable. The 
number of legs treated with attempted re- 
vascularisation (successful or failed) increased by 55 
(from 155 to 210), and the number of successfully 
revascularised legs increased by 50 (from 104 to 154). 
For patients treated in the second period the risk of 
amputation was half of that for patients treated in the 
first period, adjusting for age, sex and diabetes (relative 
risk=0,49,p =0.0001, Table 3). 
Overall limb salvage rate at 30 months, calculated 
from the day of amputation for those legs that had a 
primary amputation and from the day of re- 
vascularisation for those selected for attempted re- 
vascularisation, was 37% for the first period and 53% 
for the second (p<0.0000, Fig. 2). The number of 
patients treated bilaterally with attempted re- 
vascularisation for limb-threatening ischaemia was 18 
during the first and 26 during the second period. The 
total number of attempted revascularisations for limb- 
threatening ischaemia, including reoperations, was 180 
in the first and 254 in the second period. The total 
number of amputations, including primary am- 
putations, secondary amputations and reamputations, 
was 200 in the first and 156 in the second period. 
Chronic severe ischaemia 
The increased rate of vascular procedures for limb- 
threatening ischaemia was mainly due to an increase 
in the number of legs treated for chronic severe isch- 
aemia by 44, from 77 to 121 (Fig. 1). Forty-six (59.7%) 
of the 77 legs treated for chronic severe ischaemia 
during the first period had ulceration or gangrene, and 
the remainder had rest pain alone. The corresponding 
numbers for the second period were 72 of 121 (59.5%). 
The number of bypasses for chronic severe ischaemia 
increased from 48 to 85, while the number of per- 
cutaneous transluminal angioplasties (PTAs) was 16 
during the first and 19 during the second period. This 
should be compared to the number of PTAs performed 
for claudication, which increased from eight to 45. 
One hundred and fourteen infragenicular procedures 
were performed for chronic severe ischaemia. During 
the first period, 18 of 46 infragenicular reconstructions 
were to crural arteries. The corresponding numbers 
for the second period were 41 out of 68 (p<0.05). 
Acute ischaemia 
The number of legs treated with attempted re- 
vascularisation for acute ischaemia increased by 11, 
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from 78 to 89 (Fig. 1). During the first period the 
predominant treatment was thrombectomy or em- 
bolectomy, only two bypasses being performed, while 
during the second period there were 14 bypasses 
(p<0.01). No thrombolysis was performed during 
either period. 
Amputations 
During 1992 only two patients belonging to the catch- 
ment area of the hospital of Varberg were amputated 
at another hospital. Before 1992 no patients were al- 
lowed to attend other hospitals unless referred from 
Varberg. The annual rate of amputations was constant 
within each period. The number of legs amputated 
secondarily to procedures performed for other in- 
dications than limb-threatening ischaemia, i.e. ab- 
dominal aortic aneurysm and claudication, was 6/135 
(4.4%) during the first period and 2/295 (0.7%) during 
the second (p = 0.05). Thus the total number of legs 
amputated for arterial disease was 171 and 137 during 
the two periods. Sixty-five percent of those patients 
who suffered a secondary amputation had been am- 
putated within l month from the first vascular pro- 
cedure, 82% within 3 months and all within 32 months. 
The mean time from the first vascular procedure to 
the first amputation was 2.7 months. The two periods 
were identical in these respects. 
During the first period 74 (65%) of those 114 legs 
that had been treated with primary amputation had 
been evaluated by a vascular surgeon, a d during the 
second period 51 of 79 legs (65%). Angiography had 
been performed on 39 (53%) of the 74 legs that had 
been evaluated uring the first period and on 33 (64%) 
of 51 legs during the second period. The reduced 
amputation rate observed uring the second period 
was exclusively accounted for by a reduction of am- 
putations below the knee. During the first period 127 
legs were amputated below the knee and 44 above or 
through the knee. The corresponding umbers for the 
second period were 91 and 46. 
The number of patients amputated bilaterally for 
limb-threatening ischaemia was 22 during the first and 
12 during the second period. 
Survival and limb salvage rate 
Survival was similar in both periods for patients 
treated for limb-threatening ischaemia. One month 
after the initial procedure (primary amputation or 
attempted revascularisation), 14% of patients treated 
in the first period and 12% of those treated in the 
second period had died. After 48 months, 58% of those 
treated in the first period and 57% of those treated in 
the second period had died (Fig. 3). Comparing period 
2 to period 1, the relative risk of death within 3 months 
was 0.81 (p = 0.33), and within 1 year 1.23 (p = 0.27). 
Adjusting for age, sex and diabetes, or for choice 
of first treatment (primary amputation or attempted 
revascularisation) had no influence on the relative 
risk of death (Table 4(a)). After 3 months, mortality 
increased slowly over time with no apparent re- 
lationship to the initial procedure. In contrast to mor- 
tality, the rate of amputations differed between the 
two periods. After 1 month, 54% of patients treated 
in the first period had been amputated, and 40% of 
those treated in the second period. Comparing the 
second period to the first at six different intervals after 
the initial procedure, the relative risk of amputation 
ranged between 0.55 and 0.58 (0.001<p<0.003). Ad-
justing for age, sex and diabetes had no influence on 
the relative risk of amputation, but adjusting for choice 
of first treatment (primary amputation or attempted 
revascularisation) the relative risk approached values 
that were not statistically different from 1 (relative 
risk: range 0.63-0.70, 0.06<p<0.16, Table 4(t))). There 
was an apparent emporal relationship between the 
initial attempted revascularisation a d secondary am- 
putation, most secondary amputations having been 
performed within 3 months (Figs 2 and 3, Table 5). 
Including only patients who were still alive at the 
end of each interval, the relative risk of amputation 
at 4 years, adjusted for age, sex and diabetes, was 0.35 
(p<0.002), comparing the second to the first period. 
Adjusting for choice of first treatment, the relative risk 
was not significantly different from 1 (relative risk = 
0.77, p = 0.49, Table 4(c)). 
The changes over time of the relationship between 
mortality and amputations are summarised in Fig. 3 
and Table 5, where the proportions of deceased and 
living patients with intact and primarily or secondarily 
amputated legs are shown by period at six different 
intervals after the first treatment. Among survivors 
the proportion of patients with intact legs was higher 
in the second period than in the first, while no dif- 
ference was found in this respect among deceased 
patients. For survivors treated in the second period, 
the ratio of patients with intact legs to patients with 
primary amputation i creased from 2.4 after 1 month 
to 4.8 after 48 months, while for survivors treated in 
the first period the ratio remained below 1.2. For 
deceased patients the ratio remained at or below i for 
both periods. 
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1 Month 
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Fig. 3. Proportions of deceased and living patients with intact (succ revasc) and primarily (prim amp) or secondarily (sec amp) amputated 
legs are shown at six different intervals after the first treatment, by treatment period. Numerical values (%) are shown in Table 5. Among 
survivors the proportion of patients with intact legs was higher in the second period than in the first, while no difference was found in 
this respect among deceased patients. For survivors treated in the second period, the ratio of patients with intact legs to patients with 
primary amputation i creased from 2.4 after i month to 4.8 after 48 months, while for survivors treated in the first period the ratio 
remained below 1.2. For deceased patients the ratio remained at or below 1 for both periods. ([1) Alive, succ revasc; ( I)  alive, sec amp; 
([]) alive, prim amp; ([]) dead, prim amp; (1) dead, sec amp; ([]) dead, succ revasc. 
A comparison of survival between the two periods 
for the three subgroups of patients treated for limb- 
threatening ischaemia (successful revascularisation, 
primary and secondary amputation) revealed a dif- 
ference only for those patients who had a primary 
amputation. The median survival time for those 95 
patients who had a primary amputation during the 
first period was 24.3 months and their 2-year survival 
rate was 52.1%. The corresponding numbers were 4.1 
months and 27.3% for those 73 who were left for 
primary amputation during the second period 
(p<0.0006). 
Survival was better for patients who had a successful 
revascularisation than for those who suffered an at- 
tempted but failed revascularisation, or for those who 
had a primary amputation. The median survival time 
for those 225 patients who had a successful re- 
vascularisation was 42.8 months, and their 2-year sur- 
vival rate was 58.8%. The corresponding figures for 
those 96 who eventually had a secondary amputation 
were 20.9 months and 48.0%, respectively (p =0.007), 
and for those 168 who had a pr imary amputation 15.0 
months and 41.3%, respectively (p<0.0000). There was 
no statistically significant difference between primarily 
and secondarily amputated patients (p=0.12). 
Discussion 
This retrospective study gives a complete account of 
all vascular procedures and all major leg amputations 
performed during 8 years at a district hospital. It 
probably reflects the results of the average district 
hospital and applies more to clinical reality than stud- 
ies carried out at specialised referral centres. The catch- 
ment area of the hospital is well defined, and with very 
few exceptions all patients within the area attended the 
same hospital for peripheral vascular disease. 
The incidence of vascular interventions and am- 
putations often change gradually over time with no 
sharp delimitations, making comparisons difficult. 16 In 
the present study two consecutive 4-year periods were 
identified, distinctly separated by different rates of 
vascular intervention. 
Most factors pertinent o the question of whether 
vascular surgery prevents amputation were thor- 
oughly recorded, i.e. demographic factors; indications 
for and types and levels of vascular interventions and 
amputations; mortality and the chronological re- 
lationship between vascular econstruction and death 
or  amputation. 6'7'16'22'23 Interventions for other in- 
dications than limb-threatening ischaemia were 
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Table 4. (a) Mortality at six different intervals from the initial procedure for all patients treated for limb-threatening ischaemia (n = 
232 in period 1 and n=257 in period 2). The relative risk of death within each interval is the odds for patients treated in the second 
period divided by the odds for patients treated in the first period. The relative risk was adjusted for age, sex and diabetes, as well as 
for choice of treatment (revascularisation vs. primary amputation). 
Time from Mortality Relative risk Relative risk Relative risk 
operation (%) (Crude) (Adjusted (Adjusted 
for age, sex, diabetes) for choice of treatment) 
Period 1 Period 2 RR P RR P RR P 
1 month 14 12 0.82 0.47 0.87 0.61 0.85 0.56 
3 months 25 22 0.81 0.33 0.84 0.46 0.87 0.52 
6 months 31 31 0.96 0.84 1.01 0.96 1.03 0.86 
12 months 37 41 1.23 0.27 1.29 0.18 1.32 0.15 
24 months 48 50 1.09 0.63 1.13 0.52 1.20 0.31 
48 months 58 57 0.94 0.73 0.95 0.81 1.05 0.79 
Table 4. (b) Amputations (primary and secondary) at six different intervals from the initial procedure for all patients treated for limb- 
threatening ischaemia (n=232 in period 1 and n =257 in period 2). The relative risk of amputation with in each interval is the odds 
for patients treated in the Second period divided by the odds for patients treated in the first period. The relative risk was adjusted 
for age, sex and diabetes, as well as for choice of treatment (revascularisation vs. primary amputation). 
Time from Amputation:. Relative risk Relative risk Relative risk 
operation per cent of Tpatients (Crude) (Adjusted (Adjusted 
amputated for age, sex, diabetes) for choice of treatment) 
Period l Period 2 RR P RR P RR P 
1 month 54 40 0.57 0.002 0.54 0.001 0.67 0.15 
3 months 57 44 0.58 0.003 0.55 0.002 0.70 0.16 
6 months 60 45 0.55 0.0009 0.52 0.0008 0.63 0.06 
12 months 60 46 0.55 0.001 0.53 0.0009 0.64 0.07 
24 months 61 47 0,57 0.002 0.55 0.003 0.68 0.12 
48 months 61 47 0.58 0.003 0.56 0.002 0.68 0.12 
Table 4. (c) Amputations (primary and secondary) at six different intervals from the initial procedure for patients who were alive at 
the end of each interval. The relative risk of amputation within each interval is the odds for patients treated in the second period 
divided by the odds for patients treated in the first period. The relative risk was adjusted for age, sex and diabetes, as well as for 
choice of treatment (revascularisation vs. primary amputation). 
Time from Per cent of patients Relative risk Relative risk Relative risk 
operation amputated (Crude) (Adjusted (Adjusted 
(number of patients for age, sex, diabetes) for choice of treatment) 
alive at end of interval) 
Period 1 Period 2 RR P RR P RR P 
1 month 53 (198) 38 (226) 0.54 0.002 0.52 0.002 0.81 0.50 
3 months 54 (172) 38 (201) 0.52 0.002 0.49 0.001 0.92 0.79 
6 months 56 (158) 36 (178) 0.44 0.0002 0.42 0.002 0.73 0.32 
12 months 58 (146) 37 (150) 0.42 0.0002 0.39 0.0002 0.69 0.26 
24 months 60 (121) 35 (129) 0.40 0.0005 0.36 0.0003 0.74 0.39 
48 months 55 (97) 33 (112) 0.41 0.0018 0.35 0.0006 0.77 0.49 
considered a potent ia l  amputat ion  threat 16 and were 
therefore inc luded in the study. Pr imary  and  secondary 
amputat ions  were accounted for separately, and  sec- 
ondary  amputat ions  were related to the indicat ions 
for the init ial vascular procedure.  
Limb salvage 
The rate of vascular intervent ions for l imb-threaten ing 
ischaemia increased from the first to the second per iod 
by 65%, whi le the rate of amputat ions  decreased by 
23%. The quest ion is whether  the lowered amputat ion  
rate was due to the increased rate of vascular re- 
construct ions or had other causes. 
The fact that the reduced amputat ion  rate was ex- 
clusively on behalf  on primary amputat ions ,  am- 
putat ions  econdary to vascular intervent ions for l imb- 
threatening ischaemia be ing stable, favours the ex- 
p lanat ion that more legs were selected for re- 
vascular isat ion than amputat ion.  This explanat ion is
further supported by the close numer ica l  relat ionship 
between the increased number  of successful ly 
revascular ised legs and the reduced number  of 
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Table 5. Patients treated for limb-threatening ischaemia during period 1 (n = 232) and period 2 (n = 257), by result (dead or alive with 
intact and primarily or secondarily amputated legs) at six different intervals after the first treatment. Each category is shown in per 
cent of all patients treated within each period. In the first period 60% were selected for revascularisation and 40% had a primary 
amputation. In the second period 72% were revascularised and 28% had a primary amputations. The proportions are shown graphically 
in Fig. 3. P1 = period 1, P2 = period 2. 
Time from % Alive with % Alive with % Alive with % Dead with % Dead with % Dead with 
operation intact leg secondary primary intact leg secondary primary 
ampuation amputation amputation amputation 
P1 P2 P1 P2 P1 P2 P1 P2 P1 P2 P1 P2 
1month 40 56 10 10 36 23 5 5 4 1 5 5 
3months 35 50 9 12 31 17 8 7 7 3 10 11 
6months 31 45 10 11 28 14 11 10 9 5 12 14 
12months 27 37 11 11 26 11 13 17 9 7 14 17 
24months 22 32 9 10 21 8 17 21 12 9 19 20 
48months 19 29 7 8 16 6 20 24 13 10 25 23 
amputated legs within the group with limb-threat- 
ening ischaemia, and by the fact that practically no 
patients had been treated at other hospitals. The rate 
of amputations econdary to interventions for other 
causes than limb-threatening ischaemia was low and 
did not affect the overall amputation rate. 
The reduced amputation rate might be explained 
by a reduced incidence of limb-threatening ischaemia. 
However, the number of patients and legs treated 
for limb-threatening ischaemia with either attempted 
revascularisation r primary amputation increased by 
6.6%, and 7.4%, respectively, which compares well 
with the 8.6% increase of the elderly population. This 
indicates a true increase of the incidence of limb- 
threatening ischaemia, in good agreement with other 
reports.l-3,4,6,7,19,20,24 
There are several reasons to assume that, among legs 
classified as limb-threatening ischaemia, the severity of 
ischaemia did not decrease from the first to the second 
period. Firstly, the number of secondarily amputated 
legs increased by 9.8%, which is slightly more than 
would be expected from the increase of the elderly 
population or from the increase of the incidence of 
limb threatening ischaemia. Secondly, the marked in- 
crease of reconstructions for claudication speaks 
against the assumption that there may have been 
more claudicants among patients classified as limb- 
threatening ischaemia during the second period. 
Thirdly, chronic severe ischaemia was defined equally 
over both periods as rest pain, ulceration or gangrene, 
regardless of ankle pressure, In this group the pro- 
portion of legs with ulceration or gangrene was 60% 
during both periods, and the amputation rate was 22% 
in the group with rest pain alone and 28% in the 
group with ulceration or gangrene with no statistically 
significant difference. The proportion of legs with 
ulceration or gangrene in this group was higher than 
that of similar groups classified in other studies as 
critical limb ischaemia ccording to the Second Euro- 
pean Consensus for Critical Limb Ischaemia, 5 and the 
ischaemia was comparable to Fontaine Stages III and 
IV, 25 The use of ankle pressure as a criterion for critical 
limb ischaemia has been criticised, 26 and new defin- 
itions have been suggested. 27-3° Fourthly, acute isch- 
aemia included all emergency cases with arterial 
embolisation or thrombosis as defined on clinical 
grounds alone according to the Swedish Vascular Re- 
gistry and to the Working party of the International 
Vascular Symposium, I-3'31 and there was no doubt 
concerning the amputation threat. The number of legs 
treated with attempted revascularisation foracute isch- 
aemia increased by 14%. This is somewhat higher than 
the 8.6% increase of the elderly population, but lower 
than the increase of reconstructions for chronic severe 
ischaemia (35%), and probably only reflects the higher 
preference for revascularisation than for amputation 
during the second period. 
The natural history of critical imb ischaemia shows 
that not all legs with limb-threatening ischaemia will 
be amputated. 32'33 A better conservative treatment of 
patients with critical limb ischaemia, especially those 
with diabetic foot lesions, has been claimed to reduce 
the amputation rate. 34 A higher preference for con- 
servative treatment may partly explain the reduction 
of primary amputations. Regarding secondary am- 
putations, there may have been an increasing tendency 
over time to defer an expected amputation, even bey- 
ond the patient's death, for instance, by repeated re- 
operations, thereby masking a true increase of the 
amputation rate. However, conservative treatment 
cannot explain the reduced amputation rate for the 
following reasons. 
(i) The natural history of chronic critical limb isch- 
aemia shows that no more than 25% of patients remain 
alive with intact legs after 5 years. 33 For acute ischaemia 
the proportion is smaller. It is therefore unlikely that, 
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in the present study, the reduction of amputated legs 
by 30% from one 4-year period to another can be 
attributed to conservative treatment, even if, hy- 
pothetically, no legs had been treated conservatively 
during the first period and all legs had been treated 
conservatively during the second period. 
(ii) The proportion of diabetics treated with re- 
vascularisation for limb-threatening ischaemia was, if 
anything, increased from the first to the second period, 
indicating a more aggressive attitude for re- 
construction i  these cases. 
(iii) During both periods, 65% of all secondary am- 
putations had been performed within 1 month from 
the first attempted revascularisation, 82% within 3 
months and all amputations within 32 months. Each 
observation period spanned over 48 months. The mean 
time from the initial vascular procedure to the first 
amputation was less than 3 months for both periods, 
and survival from the initial vascular procedure did 
not differ between the two periods. Furthermore, the 
number of reoperations decreased from the first to the 
second period. 
Survival 
Patients with successful revascularisation had a better 
survival than patients who suffered a failed re- 
vascularisation. This observation agrees with other 
studies. 4'23'35 The improved survival may be a direct 
effect of the successful procedure itself, 4'23 but it more 
probably reflects a selection mechanism. An as- 
sociation has been demonstrated between severity of 
lower limb ischaemia, involvement of crural arteries, 
more generalised isease and, hence, increased mor- 
tality. B6 Accordingly, patients who had good chances 
of successful revascularisation also had good chances 
of surviving regardless of treatment modality, im- 
plying that these patients would have survived also 
if amputation had been preferred. This seems natural, 
considering that amputation is a life-saving procedure. 
Likewise, the poorer survival among patients who had 
a primary amputation i  the second period compared 
to the first period probably reflects the same selection 
mechanism: those fewer patients who were considered 
not suitable for revascularisation in the second period 
had poorer chances of surviving. 
Thus the choice of initial treatment did not influence 
mortality, but due to the higher preference for re- 
vascularisation i the second period more survivors 
were selected from amputation to revascularisation. 
This conclusion is supported in the present study by 
the observation that mortality was similar in both 
periods despite the different rates of revascularisation. 
In contrast o this, the risk of amputation was sig- 
nificantly lower for patients treated in the second 
period compared to patients treated in the first period, 
but adjusting for choice of initial treatment (re- 
vascularisation or primary amputation), the relative 
risk of amputation was not significantly different from 
1. Moreover, mortality increased gradually over time 
with no apparent relationship to the initial procedure, 
whether amputation or revascularisation, while almost 
all secondary amputations had been performed within 
a few months after the initial revascularisation. Finally, 
mortality was similar after primary amputation and 
failed revascularisation, i  good agreement with other 
studies. 37 
This conclusion has ethical and economical im- 
plications. Amputation is by far more expensive than 
revascularisation. 6'3839 If survival is more dependent 
on the qualities of the patient han on treatment mod- 
ality, the ability of the vascular surgeon to select hese 
patients decides whether they shall spend the rest of 
their lives as amputees or not. 
On the other hand, more liberal indications for 
vascular surgery may entail more failures. It appears 
from the rates of secondary amputations that this was 
not the case for either limb-threatening ischaemia or 
other indications, nor did the number of reoperations 
increase. However, as most secondary amputations 
were performed within 3 months after attempted re- 
vascularisation, it is important to identify such patients 
in order to reduce the number of unnecessary attempts 
at revascularisation and to reduce tile suffering of 
these patients by primary amputation. Quality of life 
scores are only slightly poorer after failed re- 
vascularisation than after successful revascularisation, 
probably because patients selected for re- 
vascularisation may have a better potential for re- 
habilitation. 4°
Another concern is the group of patients who died 
with intact leg. It appears from Fig. 3 and from Table 
5 that this group was relatively small after 1 month 
(5%) but increased continuously to 10% at 6 months 
and to 20-24% after 4 years. The present study shows 
that if a revascularised leg remained intact beyond 
3-4 months, the leg was highly probable to remain 
intact for the rest of the patient's life. Beyond this 
point, the benefit of the revascularisation was reduced 
only by the patient's death, it would be interesting to 
know if this experience is shared by other vascular 
units. If so, 3-4 months' amputation-free survival 
seems, from an ethical point of view, to be the lower 
limit above which revascularisation is justified. This 
limit may coincide with the lower limit of economical 
benefit. 4°-43 
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